SCHEMBL6892767

SCHEMBL6892767

O=C1c2ccccc2C(=O)N1Cc1ncn2ccsc12

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
PKM P14618 1/20 0.43
TSHR P16473 3/20 0.42
KDM4E B2RXH2 1/20 0.40
CASP3 P42574 1/20 0.38
MAPT P10636 2/20 0.36
POLB P06746 1/20 0.36
HPGD P15428 1/20 0.36
NPC1 O15118 1/20 0.36
TP53 P04637 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
PRMT5 O14744 1/20 0.36
WDR77 Q9BQA1 1/20 0.36
MAPK1 P28482 1/20 0.36
CREBBP Q92793 1/20 0.36
RECQL P46063 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8041339 0.67 ALDH1A1 (0.43) ALDH1A1MEN1KMT2APKMTSHR
SCHEMBL4652782 0.66 ALDH1A1 (0.45) ALDH1A1MEN1KMT2APKMTSHR
SCHEMBL1619449 0.64 ALDH1A1 (0.68) ALDH1A1MEN1KMT2APKMTSHR
SCHEMBL399990 0.64 ALDH1A1 (0.54) ALDH1A1MEN1KMT2APKMKDM4E
SCHEMBL29940891 0.64 ALDH1A1 (0.54) ALDH1A1MEN1KMT2APKMTSHR
SCHEMBL25344861 0.64 ALDH1A1 (0.46) ALDH1A1MEN1KMT2APKMKDM4E
SCHEMBL31440112 0.64 ALDH1A1 (0.46) ALDH1A1MEN1KMT2APKMKDM4E
SCHEMBL29843133 0.63 ALDH1A1 (0.68) ALDH1A1MEN1KMT2APKMTSHR
SCHEMBL10430902 0.63 ALDH1A1 (0.68) ALDH1A1MEN1KMT2APKMTSHR
SCHEMBL14907985 0.63 ALDH1A1 (0.49) ALDH1A1MEN1KMT2APKMTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6677331-B2 HAVING SUBSTITUTED IMIDAZO(5,1-B)THIAZOLE GROUP AT 2-POSITION; MICROBIOCIDES AGAINST BETA-LACTAMASE PRODUCING BACTERIA AND RESISTANT PSEUDOMONAS MEIJI SEIKA KAISHA, LTD. (JP) 2004-01-13 US disclosed
US-20030149016-A1 Novel carbapenem derivatives KANO YUKO (JP) 2003-08-07 US disclosed
US-6458780-B1 IMIDAZO(5,1-B)THIAZOLE GROUP AT THE 2-POSITION ON THE CARBAPENEM RING HAVE HIGH ANTI-MICROBIAL ACTIVITIES AGAINST .BETA.-LACTAMASE PRODUCING BACTERIA, MRSA, RESISTANT-PSEUDOMONAS AERUGINOSA, PRSP, ENTEROCOCCI, AND MEIJI SEIKA KAISHA, LTD. (JP) 2002-10-01 US disclosed
EP-1101766-A1 NOVEL CARBAPENEM DERIVATIVES MEIJI SEIKA KAISHA LTD. (JP) 2001-05-23 EP disclosed
EP-0669336-B1 NOVEL CEPHEM DERIVATIVES MEIJI SEIKA CO (JP) 2000-05-17 EP disclosed
US-5663162-A BACTERICIDES AND ANTIBIOTICS MEIJI SEIKA KABUSHIKI KAISHA (JP) 1997-09-02 US disclosed
EP-0669336-A1 NOVEL CEPHEM DERIVATIVE MEIJI SEIKA KABUSHIKI KAISHA (JP) 1995-08-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030149016-A1 Novel carbapenem derivatives DPEP1, TMPRSS15, STK35 ALDH1A1 1161/4885MEN1 2832/4885KMT2A 3040/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.